Trials / Sponsors / Nabriva Therapeutics AG

Nabriva Therapeutics AG

Industry · 9 registered clinical trials.

Status	Trial	Phase	Started
Completed	Study to Assess the Safety and PK of Oral and IV Xenleta in Adults With Cystic Fibrosis Cystic Fibrosis	Phase 1	2022-03-01
Unknown	PK Study of Single-Dose ZTI-01 in Children (<12 Years of Age) Pediatric ALL	Phase 1	2018-05-24
Completed	4-way Crossover QT Evaluation in Healthy Subjects Cardiac Repolarization in Healthy Subjects	Phase 1	2018-01-11
Completed	A Study to Assess Mass Balance Recovery, Metabolite Profile and Identification of IV and Oral 14C-BC-3781 Healthy	Phase 1	2017-01-08
Completed	Study to Compare Lefamulin to Moxifloxacin for the Treatment of Adults With Pneumonia Community Acquired Pneumonia	Phase 3	2016-08-01
Completed	Safety and Efficacy of ZTI-01 (IV Fosfomycin) vs Piperacillin/Tazobactam for Treatment cUTI/AP Infections Urinary Tract Infection Symptomatic, Acute Pyelonephritis, Urinary Tract Infection Complicated	Phase 2 / Phase 3	2016-04-01
Completed	Study to Compare Lefamulin to Moxifloxacin (With or Without Linezolid) for the Treatment of Adults With Pneumo Community Acquired Pneumonia	Phase 3	2015-09-01
Completed	Bioavailability and Pharmacokinetics of Lefamulin When Administered to Fed and Fasted Healthy Subjects Healthy	Phase 1	2015-06-01
Completed	Study Comparing the Safety and Efficacy of Two Doses of BC-3781 vs Vancomycin in Patients With Acute Bacterial Bacterial Infections, Infection	Phase 2	2010-05-01